Acetazolamide and topiramate-induced clinically significant metabolic acidosis and weight loss in idiopathic intracranial hypertension: a case report and pharmacovigilance analysis
- DOI
- 10.1007/s00210-026-05880-y
- Published
- 2026-08-31
- Container
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00210-026-05880-y,
title = {Acetazolamide and topiramate-induced clinically significant metabolic acidosis and weight loss in idiopathic intracranial hypertension: a case report and pharmacovigilance analysis},
author = {Berke Şentürk and Eda Yılmaz and Hatice Nur Aslan and Berivan Yakut-Öner and Hülya Tezel-Yalçın and Berke Cural and Lale Özışık and Nadir Yalçın},
year = {2026},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
doi = {10.1007/s00210-026-05880-y},
url = {https://doi.org/10.1007/s00210-026-05880-y}
}RIS
TY - JOUR TI - Acetazolamide and topiramate-induced clinically significant metabolic acidosis and weight loss in idiopathic intracranial hypertension: a case report and pharmacovigilance analysis AU - Berke Şentürk AU - Eda Yılmaz AU - Hatice Nur Aslan AU - Berivan Yakut-Öner AU - Hülya Tezel-Yalçın AU - Berke Cural AU - Lale Özışık AU - Nadir Yalçın PY - 2026 JO - Naunyn-Schmiedeberg's Archives of Pharmacology DO - 10.1007/s00210-026-05880-y UR - https://doi.org/10.1007/s00210-026-05880-y ER -
APA
Şentürk, B., Yılmaz, E., Aslan, H. N., Yakut-Öner, B., Tezel-Yalçın, H., Cural, B., Özışık, L., & Yalçın, N. (2026). Acetazolamide and topiramate-induced clinically significant metabolic acidosis and weight loss in idiopathic intracranial hypertension: a case report and pharmacovigilance analysis. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05880-y
Source records
- crossref · retrieved 2026-09-27T05:55:41.807Z